Archive: Therigy partners with Schnucks and Kerr Health to develop Therapy Management Protocol for HIV

Today Therigy announced the release of its specialty therapy management (STM) protocol for HIV. The new HIV program is available to pharmacies using therigySTM — a HIPAA-compliant specialty therapy management Web application.

Therigy's HIV STM protocol covers more than 60 medications and is designed to support certified HIV clinical specialists in managing their patients. The protocol was created with the assistance of certified HIV clinical specialists on staff at St. Louis-based Schnuck Pharmacy, a division of Schnuck Markets, Inc., and North Carolina-based Kerr Health.

"We are honored to have the opportunity to work with Schnucks and Kerr in developing the content for the HIV protocol," commented Bill Bailey, Therigy's VP Pharmacy Services. "It was a valiant effort by all parties to put together this in-depth clinical model. As always, Therigy is dedicated to bringing our clients the best-in-class specialty therapy management programs, and always willing to work with clients to achieve that goal."We are excited about the opportunity to enhance our patient adherence offering, "said Jerry Lamb, Kerr Health VP of Operations. "HIV providers appreciate the close interaction and extraordinary lengths we go to in maintaining a clear channel of communications with our diverse HIV patient base. The integration and customization afforded by Therigy's STM protocol will permit Kerr Health to apply an even greater degree of patient monitoring and data recording capabilities--resulting in higher compliance rates and better patient health outcomes."

Mike Juergensmeyer, Schnucks' Vice President of Pharmacy, says Schnucks Pharmacy has specialized in HIV care for nearly three years. The company now operates a centralized specialty facility and four satellite specialty pharmacies dedicated to HIV care. Most recently, they established an office in Food Outreach, a local non-profit organization that focuses on the care and treatment of HIV and cancer patients.

Juergensmeyer said, "Research proves there is a strong correlation between healthy diet and successful treatment of disease. Over the past few years Schnucks Pharmacy has looked for ways in which we can marry the two in the treatment of our chronically ill pharmacy patients."

"We've worked with Therigy to design clinical programs that will enable us to more closely monitor our chronically ill cancer and HIV patients. Tracking their medication, diet, and overall progress, we are able to partner with physicians to deliver a higher level of care and provide for better patient outcomes," Juergensmeyer said. "TherigySTM will take our services to the next level by helping us to more efficiently assess each patient's progress and manage drug therapy, allowing us to provide a high level of care, more targeted counseling and better outcomes for our chronically ill patients."

These assessments are deployed within the application and are available for use to TherigySTM subscribers. If you would like to schedule a demonstration of TherigySTM or to learn more about Therigy products and services, please contact Bill Bailey, VP of Pharmacy Services, at 407-992-8753.

For more information about this press release, please contact Lindsey Harris, Director of Marketing at Therigy, LLC, at or 407-992-8750 ext. 126.

About Kerr Health

Kerr Health is a leading regional health care services provider focused on delivering exceptional value and clinical leadership through its three primary service lines: Specialty Pharmacy, Long-Term Care Pharmacy Services, and Care Management. As a subsidiary of Kerr Drug, Inc., one of the nation's leading and most respected names in the chain drug industry (2010 Drug Topics Chain of the Year), Kerr Health provides a broad and customizable offering of value-driven products and services to medical practices, patients, employer groups, long-term care facilities, and municipalities.

For information on Kerr Health, please contact Jerry Lamb, vice president of Operations, at 919-534-1385

About Schnuck Markets, Inc.

Founded in St. Louis in 1939, Schnuck Markets, Inc. operates 105 stores (including five Logli stores) and 101 in-store pharmacies in Missouri, Illinois, Indiana, Wisconsin, Iowa, Tennessee and Mississippi.For information on Schnucks Specialty Pharmacy Division, please contact Dave Chism, supervisor of Specialty Pharmacy/PBM Services, at 314-344-9636.